Loss of S-100-positive Schwann cells is a feature of JAK2 V617F-positive myeloproliferative neoplasm

被引：1
|
作者：
Bihari, Chhagan [1 ]
Rastogi, Archana [1 ]
Saxena, Priyanka [2 ]
Kumar, Anupam [3 ]
机构：
[1] Inst Liver & Biliary Sci, Dept Pathol, New Delhi, India
[2] Inst Liver & Biliary Sci, Dept Hematol, New Delhi, India
[3] Inst Liver & Biliary Sci, Dept Res, New Delhi, India
来源：
ANNALS OF HEMATOLOGY | 2015年 / 94卷 / 08期
关键词：
NICHE;
D O I：
10.1007/s00277-015-2396-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1427 / 1429
页数：3
相关论文
共 50 条
  • [1] Loss of S-100-positive Schwann cells is a feature of JAK2 V617F-positive myeloproliferative neoplasm
    Chhagan Bihari
    Archana Rastogi
    Priyanka Saxena
    Anupam Kumar
    Annals of Hematology, 2015, 94 : 1427 - 1429
  • [2] Gender Differences In the Prevalence of Thrombosis In the JAK2 V617F-Positive Myeloproliferative Disorders
    Stein, Brady L.
    Moliterno, Alison R.
    Spivak, Jerry L.
    BLOOD, 2010, 116 (21) : 1270 - 1270
  • [3] A GERMLINE JAK2 SNP IS ASSOCIATED WITH PREDISPOSITION TO THE DEVELOPMENT OF JAK2 V617F-POSITIVE MYELOPROLIFERATIVE NEOPLASMS
    Kilpivaara, M.
    Mukherjee, S.
    Schram, M.
    Wadleigh, M.
    Mullally, A.
    Ebert, L.
    Bass, A.
    Marubayashi, S.
    Heguy, A.
    Garcia-Manero, G.
    Kantarjian, H.
    Offit, K.
    Stone, M.
    Gilliland, D.
    Klein, J.
    Levine, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 420 - 420
  • [4] Disease burden at the progenitor level is a feature of primary myelofibrosis a multivariable analysis of 164 JAK2 V617F-positive myeloproliferative neoplasm patients
    Stein, Brady L.
    Williams, Donna M.
    Rogers, Ophelia
    Isaacs, Mary Ann
    Spivak, Jerry L.
    Moliterno, Alison R.
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (01) : 95 - 101
  • [5] Mesenteric venous thrombosis secondary to an unsuspected JAK2 V617F-positive myeloproliferative disorder
    M. G. Bourke
    S. T. Martin
    M. O’Dwyer
    J. Hanaghan
    F. Bennani
    M. K. Barry
    Irish Journal of Medical Science, 2012, 181 : 285 - 287
  • [6] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
    Mayumi Tanaka
    Toshiaki Yujiri
    Shunsuke Ito
    Naoko Okayama
    Toru Takahashi
    Kenji Shinohara
    Yoichi Azuno
    Ryouhei Nawata
    Yuji Hinoda
    Yukio Tanizawa
    International Journal of Hematology, 2013, 97 : 409 - 413
  • [7] The relevance of HLA class II genes in JAK2 V617F-positive myeloproliferative neoplasms
    Shivarov, Velizar
    Tsvetkova, Gergana
    Hadjiev, Evgueniy
    Ivanova, Milena
    HUMAN IMMUNOLOGY, 2023, 84 (03) : 199 - 207
  • [8] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
    Tanaka, Mayumi
    Yujiri, Toshiaki
    Ito, Shunsuke
    Okayama, Naoko
    Takahashi, Toru
    Shinohara, Kenji
    Azuno, Yoichi
    Nawata, Ryouhei
    Hinoda, Yuji
    Tanizawa, Yukio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 409 - 413
  • [9] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Brazilian patients
    Macedo, L. C.
    Santos, B. C.
    Pagliarini-E-Silva, S.
    Pagnano, K. B. B.
    Rodrigues, C.
    Quintero, F. C.
    Ferreira, M. E.
    Baraldi, E. C.
    Ambrosio-Albuquerque, E. P.
    Sell, A. M.
    Visentainer, J. E. L.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (05) : 654 - 660
  • [10] Mesenteric venous thrombosis secondary to an unsuspected JAK2 V617F-positive myeloproliferative disorder
    Bourke, M. G.
    Martin, S. T.
    O'Dwyer, M.
    Hanaghan, J.
    Bennani, F.
    Barry, M. K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 (02) : 285 - 287
12345